For humans, the unpredictability of life is an existential concern. It’s a similar threat for analytical models. Like us, algorithms attempt to predict the future by...
By Ero Georgiades, Chief Operating Officer of Fountech Solutions. The last twelve months have proved to be something of a turning point within the corporate space....
An international team of researchers has applied AI models to find already existing drugs that can treat Covid-19 in elderly patients. The research team applied autoencoder...
The British government intends to employ AI systems in the review of possible safety concerns for Covid-19 vaccinations. The government of the UK has plans to...
By Eric Paternoster, CEO of Infosys Public Services So far, existing data science models haven’t done the best job at predicting the ease of transmission of COVID-19, the...
Artificial intelligence (AI) has once again been proven to be an effective tool in the fight against COVID-19. A new study out of the University of...
The National Institutes of Health has turned to artificial intelligence (AI) for diagnosis, treatment, and monitoring of COVID-19 through the creation of the Medical Imaging and...
Epistemic AI employs state-of-the-art Natural Language Processing (NLP), machine learning and deep learning algorithms to map relations among a growing body of biomedical knowledge, from multiple...
The British AI drug development company Exscientia has raised $60 million in a Series C financing round. It was led by Denmark’s Novo Holdings, which is...
Retail and service companies around the world make use of AI algorithms to predict customer behaviors, take stock of inventory, estimate marketing impacts, and detect possible...
The Covid-19 Open AI Consortium (COAI) intends to bring breakthrough medical discoveries and actionable findings to the fight against the Covid-19 pandemic. COAI aims to increase collaborative...
The Covid-19 Open AI Consortium (COAI) intends to bring breakthrough medical discoveries and actionable findings to the fight against the Covid-19 pandemic. COAI aims to increase collaborative...
The Covid-19 Open AI Consortium (COAI) intends to bring breakthrough medical discoveries and actionable findings to the fight against the Covid-19 pandemic. COAI aims to increase collaborative...
After a fresh round of funding, Owkin recently launched the Covid-19 Open AI Consortium (COAI). This consortium will enable advanced collaborative research and accelerate clinical development of...
IBM scientist Peter Staar has developed an AI tool which is being used by more than 300 experts who are developing a treatment or vaccination for...
